The ameliorative effects of virgin olive oil and olive leaf extract on amikacin-induced nephrotoxicity in the rat

Autor: Abdel-Gayoum, Abdelgayoum A., Al-Hassan, Abdelrahman A., Ginawi, Ibrahim A., Alshankyty, Ibraheem M.

Publikováno v: In Toxicology Reports 2015 2:1327-1333

Utility of Ankyrin 3 as a Prognostic Marker in Androgen-Receptor-Positive Breast Cancer Running Title: Prognostic Value of ANK3 in AR-Positive Breast Cancer

Autor: Kurozumi, Sasagu, Joseph, Chitra, Raafat, Sara, Sonbul, Sultan, Kariri, Yousif, Alsaeed, Sami, Pigera, Marian, Alsaleem, Mansour, Nolan, Christopher C, Johnston, Simon, Aleskandarany, Mohammed A, Ogden, Angela, Fujii, Takaaki, Shirabe, Ken, Martin, Stewart, Alshankyty, Ibraheem, Mongan, Nigel P, Ellis, Ian O, Green, Andrew R, Rakha, Emad A

© 2019, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: Androgen receptor (AR) and AR signaling pathways are thought to play a role in breast cancer (BC) and are potentially related to treatment responses and outcomes. Ankyri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c45e12e5f5fddf0303e6982ee71ee827

Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.

Autor: Kurozumi S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan., Joseph C; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Raafat S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Sonbul S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Kariri Y; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Alsaeed S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Pigera M; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Alsaleem M; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Nolan CC; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Johnston SJ; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Aleskandarany MA; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.; Faculty of Medicine, Menoufyia University, Shebin El Kom, Egypt., Ogden A; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Fujii T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan., Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan., Martin SG; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Alshankyty I; Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Mongan NP; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, USA., Ellis IO; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Green AR; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK., Rakha EA; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK. emad.rakha@nottingham.ac.uk.; Faculty of Medicine, Menoufyia University, Shebin El Kom, Egypt. emad.rakha@nottingham.ac.uk.; Division of Cancer and Stem Cells, Department of Histopathology, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, NG5 1PB, UK. emad.rakha@nottingham.ac.uk.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Jul; Vol. 176 (1), pp. 63-73. Date of Electronic Publication: 2019 Apr 02.